Literature DB >> 28557002

Mammalian target of rapamycin complex 1 signalling is essential for germinal centre reaction.

Bingshou Li1, Zhirong Li1, Pengcheng Wang1, Qizhao Huang1, Lifan Xu1, Ran He1, Lilin Ye1, Qiang Bai1.   

Abstract

The mammalian target of rapamycin (mTOR) is a serine-threonine kinase that has been shown to be essential for the differentiation and function of various immune cells. Earlier in vitro studies showed that mTOR signalling regulates B-cell biology by supporting their activation and proliferation. However, how mTOR signalling temporally regulates in vivo germinal centre B (GCB) cell development and differentiation into short-lived plasma cells, long-lived plasma cells and memory cells is still not well understood. In this study, we used a combined conditional/inducible knock-out system to investigate the temporal regulation of mTOR complex 1 (mTORC1) in the GCB cell response to acute lymphocytic choriomeningitis virus infection by deleting Raptor, a main component of mTORC1, specifically in B cells in pre- and late GC phase. Early Raptor deficiency strongly inhibited GCB cell proliferation and differentiation and plasma cell differentiation. Nevertheless, late GC Raptor deficiency caused only decreases in the size of memory B cells and long-lived plasma cells through poor maintenance of GCB cells, but it did not change their differentiation. Collectively, our data revealed that mTORC1 signalling supports GCB cell responses at both early and late GC phases during viral infection but does not regulate GCB cell differentiation into memory B cells and plasma cells at the late GC stage.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  B cell; cell differentiation; gene regulation

Mesh:

Substances:

Year:  2017        PMID: 28557002      PMCID: PMC5588811          DOI: 10.1111/imm.12767

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

Review 1.  Germinal centers.

Authors:  Gabriel D Victora; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

2.  Multiple layers of B cell memory with different effector functions.

Authors:  Ismail Dogan; Barbara Bertocci; Valérie Vilmont; Frédéric Delbos; Jérome Mégret; Sébastien Storck; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Nat Immunol       Date:  2009-10-25       Impact factor: 25.606

3.  Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo.

Authors:  Megan M McCausland; Shane Crotty
Journal:  J Virol Methods       Date:  2007-10-17       Impact factor: 2.014

Review 4.  AID targeting in antibody diversity.

Authors:  Rushad Pavri; Michel C Nussenzweig
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

Review 5.  Regulation of immune responses by mTOR.

Authors:  Jonathan D Powell; Kristen N Pollizzi; Emily B Heikamp; Maureen R Horton
Journal:  Annu Rev Immunol       Date:  2011-11-29       Impact factor: 28.527

Review 6.  Regulation and function of mTOR signalling in T cell fate decisions.

Authors:  Hongbo Chi
Journal:  Nat Rev Immunol       Date:  2012-04-20       Impact factor: 53.106

7.  Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.

Authors:  L S Wicker; R C Boltz; V Matt; E A Nichols; L B Peterson; N H Sigal
Journal:  Eur J Immunol       Date:  1990-10       Impact factor: 5.532

Review 8.  Dynamics of B cells in germinal centres.

Authors:  Nilushi S De Silva; Ulf Klein
Journal:  Nat Rev Immunol       Date:  2015-02-06       Impact factor: 53.106

9.  Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism.

Authors:  Terri N Iwata; Julita A Ramírez; Mark Tsang; Heon Park; Daciana H Margineantu; David M Hockenbery; Brian M Iritani
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

10.  Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells.

Authors:  Masashi Ohtani; Shigenori Nagai; Shuhei Kondo; Shinta Mizuno; Kozue Nakamura; Masanobu Tanabe; Tsutomu Takeuchi; Satoshi Matsuda; Shigeo Koyasu
Journal:  Blood       Date:  2008-05-20       Impact factor: 22.113

View more
  4 in total

Review 1.  Interventions for infantile haemangiomas of the skin.

Authors:  Monica Novoa; Eulalia Baselga; Sandra Beltran; Lucia Giraldo; Ali Shahbaz; Hector Pardo-Hernandez; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

2.  Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?

Authors:  Jasper C A Broen; Joel A G van Roon; Sofie L M Blokland; Maarten R Hillen; Catharina G K Wichers; Maili Zimmermann; Aike A Kruize; Timothy R D J Radstake
Journal:  RMD Open       Date:  2019-01-11

Review 3.  The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data.

Authors:  Aigli G Vakrakou; Anastasia Alexaki; Maria-Evgenia Brinia; Maria Anagnostouli; Leonidas Stefanis; Panos Stathopoulos
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

4.  Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells.

Authors:  Seung-Chul Choi; Anton A Titov; Georges Abboud; Howard R Seay; Todd M Brusko; Derry C Roopenian; Shahram Salek-Ardakani; Laurence Morel
Journal:  Nat Commun       Date:  2018-10-22       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.